MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
LABFF LABORATORIOS FARMACEUTOCOS ROVI SA
- 65.864
- 0.0000.00%
15min DelayClose Nov 25 16:00 ET
3.37BMarket Cap20.01P/E (TTM)
0.000High0.000Low0Volume0.000Open65.864Pre Close0.00Turnover0.00%Turnover Ratio19.86P/E (Static)51.15MShares90.61052wk High6.33P/B3.37BFloat Cap65.86452wk Low1.23Dividend TTM51.15MShs Float90.610Historical High1.87%Div YieldTTM0.00%Amplitude65.863Historical Low--Avg Price1Lot Size
LABORATORIOS FARMACEUTOCOS ROVI SA Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Net income from continuing operations | 30.74%89.36M | 50.55%37.13M | -68.92%19.01M | -14.56%220.41M | -33.77%66.23M | 29.85%68.35M | -32.24%24.67M | -11.26%61.17M | 41.25%257.97M | 71.60%100M |
| Other non cash items | 227.07%629K | 119.49%92K | 121.91%55K | 56.21%-1.68M | 80.97%-457K | -213.27%-495K | -236.42%-472K | 88.62%-251K | 32.13%-3.83M | -246.11%-2.4M |
| Change In working capital | 21.84%-44.8M | -195.14%-5.77M | 16.33%-13.61M | 39.54%-34.45M | 367.93%33.07M | -50.38%-57.32M | 12.33%6.07M | -36.55%-16.26M | 11.03%-56.97M | 71.41%-12.34M |
| -Change in receivables | -294.25%-49.13M | -72.28%7.94M | -25.17%19.1M | 172.60%19.47M | 24.44%-22.24M | -35.92%-12.46M | -5.46%28.65M | 237.79%25.52M | 63.85%-26.82M | 27.47%-29.44M |
| -Change in inventory | 189.28%11.78M | 32.52%-18.76M | 122.03%2.7M | 59.08%-29.29M | 203.41%23.96M | 51.56%-13.19M | -42.34%-27.81M | -636.98%-12.26M | -205.59%-71.59M | 9.18%-23.17M |
| -Change in prepaid assets | 97.74%-25K | 58.58%-1.25M | -136.46%-101K | ---- | ---- | ---1.11M | ---3.02M | --277K | ---- | ---- |
| -Change in other current assets | ---- | ---- | ---- | -200.00%-702K | ---- | ---- | ---- | ---- | 86.84%-234K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 11,234.28%35.41M | -49.32%14.21M | -36.58%15.54M | -52.34%113.25M | -9.69%61.03M | -153.63%-318K | -57.09%28.03M | -76.46%24.51M | 58.99%237.6M | 487.93%67.57M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Net PPE purchase and sale | -84.13%-14.75M | 30.06%-9.16M | -81.07%-8.85M | -5.47%-53.41M | 15.93%-27.41M | 2.79%-8.01M | -68.88%-13.1M | -140.33%-4.89M | -26.02%-50.64M | -76.23%-32.61M |
| Net intangibles purchase and sale | -9.46%-405K | -224.84%-510K | -743.75%-135K | -108.22%-1.39M | -160.74%-850K | -55.46%-370K | -423.33%-157K | 78.67%-16K | 7.34%-669K | 28.35%-326K |
| Net business purchase and sale | --0 | --0 | ---255K | --1.2M | --1.8M | ---600K | --0 | --0 | --0 | --0 |
| Net investment purchase and sale | --0 | --0 | --80K | 101.50%88K | --0 | --78K | --10K | --0 | ---5.85M | ---5.87M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -81.22%-15.15M | 23.72%-9.58M | -89.45%-9.15M | 8.97%-52.03M | 32.27%-26.28M | 1.38%-8.36M | -61.64%-12.55M | -129.44%-4.83M | -39.95%-57.15M | -104.69%-38.8M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Net issuance payments of debt | 326.62%6.87M | 1,311.19%37.87M | 631.99%16.13M | -140.64%-12.92M | -123.03%-3.73M | -78.35%-3.03M | -189.27%-3.13M | -231.00%-3.03M | -10.66%-5.37M | -24.59%-1.67M |
| Net common stock issuance | 101.49%271K | -14,013.54%-13.36M | -16,482.78%-34.66M | 18.12%-81.26M | -22,040.07%-62.97M | -3,217.52%-18.18M | 118.32%96K | 99.79%-209K | -172.22%-99.24M | 100.79%287K |
| Cash dividends paid | ---- | ---- | ---- | -35.37%-69.05M | --0 | ---- | ---- | ---- | -141.37%-51.01M | --0 |
| Net other financing activities | 76.84%2.84M | ---- | ---- | 102.48%2.78M | 100,000.00%999K | 31.10%1.61M | -200.00%-1K | 17.81%172K | --1.37M | ---1K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 46.73%-47.28M | 958.82%26.86M | -489.65%-18.63M | -4.08%-160.84M | -4,400.68%-65.8M | -70.35%-88.76M | -86.75%-3.13M | 96.82%-3.16M | -146.36%-154.54M | 96.10%-1.46M |
| Net cash flow | ||||||||||
| Beginning cash position | -71.02%44.58M | -90.75%13.09M | -79.73%25.32M | 26.16%124.95M | -42.26%56.38M | -2.42%153.81M | 39.05%141.46M | 26.16%124.95M | 86.29%99.04M | -32.18%97.64M |
| Current changes in cash | 72.26%-27.02M | 155.00%31.49M | -174.09%-12.24M | -484.50%-99.62M | -213.73%-31.06M | -62.42%-97.44M | -77.90%12.35M | 511.51%16.52M | -43.52%25.91M | 160.78%27.31M |
| End cash Position | -68.86%17.55M | -71.02%44.58M | -90.75%13.09M | -79.73%25.32M | -79.73%25.32M | -42.26%56.38M | -2.42%153.81M | 39.05%141.46M | 26.16%124.95M | 26.16%124.95M |
| Free cash flow | 326.57%20.25M | -69.37%4.53M | -66.56%6.55M | -68.82%58.06M | -5.79%32.63M | -12.23%-8.94M | -74.33%14.77M | -80.79%19.6M | 71.62%186.21M | 563.92%34.64M |
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.